POSTERS

Randomized trial replication using observational data for comparative effectiveness of secukinumab and ustekinumab for psoriasis

Presented at EADV Virtual 2020

Risk of Hospitalisation due to Infection in Patients with Psoriasis

Presented at ICPE All Access 2020.

Drug survival of Adalimumab, Ustekinumab and Secukinumab in Patients with Psoriasis

To be presented at ICPE All Access 2020

Timing of the Last Dose of Biologic Therapy and Risk of Post-Surgical Infections in Patients with Psoriasis

Presented at ICPE 2018

A Propensity-Score Weighting Approach to Compare Registry and Trial Populations of Patients with Psoriasis on Biologic Therapies

Presented at ICPE 2018

Development and Internal Validation of a Multivariable Risk Prediction Model for Serious Infection in Patients with Psoriasis

Presented at the International Investigative Dermatology meeting 2018 and ICPE 2018

Infliximab is Associated with an Increased Risk of Serious Infection in Patients with Psoriasis

Presented at Psoriasis Gene to Clinic Congress 2017

Examining the Risk of Serious Infection in Patients with Psoriasis - A Prospective Cohort Study from BADBIR

Presented at the ICPE and ESDR 2017

Serious Infections and Biologic Therapies for Psoriasis - A Systematic Review and Meta-analysis

Presented at BAD Annual Meeting and ICPE 2016

Drug Survival of Biologic Therapies for Psoriasis - a Prospective Cohort Study from BADBIR - Lay Summary

Presented at the NIHR trainees meeting 2015; University of Manchester Postgraduate Research Showcase

Systemic Therapies for Psoriasis and Safety in Pregnancy

Presented at BAD Annual Meeting 2014